Arabinogalactan.
Larch tree prebiotic. Immune and gut fiber. Polysaccharide from larch trees. Prebiotic and immune support. Feeds beneficial bacteria.
Reviewed March 2026
- Category
- Fiber
- Also filed under
- Gut healthImmunePrebiotic
What Arabinogalactan is, and what it does.
- Does it work
- Suits people who want a fermentable fibre that stays thin in liquid, and anyone rebuilding gut bacteria after a course of antibiotics.
- How much to take
- Start with 1g a day and build toward 3g, which is where the larch fibre earns its keep as daily food for your gut bacteria.
- Time to feel it
- Fermentation begins within a day or two, sometimes as a little extra gas. Shifts in regularity and in bifidobacteria counts take two to four weeks of daily use.
- The first dose
- Fermentation gets going within a day or two. Some people notice a little extra gas early on, and nothing else has shifted yet.
- With regular use
- Two to four weeks of daily use shifts bifidobacteria counts and short-chain fatty acid production, and regularity tends to steady over the same window.
- How well tolerated
- Well tolerated. Start low if sensitive to fiber.
- How it feels
- Unremarkable to take, since it dissolves clear and thin. A bit of gas in the first week, then steadier bathroom habits is the usual report.
- The overlooked benefit
- It stays thin in water even at high concentration, so unlike beta-glucan or guar it won't thicken a drink. That's why it can go into coffee or juice unnoticed.
1 to 3g a day is where Arabinogalactan works.
Source: Jovanovski et al. 2018 Am J Med meta-analysis; FDA health claim approval 1998
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Arabinogalactan has solid evidence. Based on 17364+ studies.
- growth of bifidobacteria and lactobacilli in the gutRandomised trial
- short-chain fatty acid production in the colonRandomised trial
- immune response markersRandomised trial
- regularity and stool frequencyRandomised trial
- shifting gut ammonia into bacterial biomassAnimal study
Questions people ask about Arabinogalactan.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Arabinogalactan resists upper gut digestion and is fermented by bifidobacteria in the colon to short chain fatty acids. Delivering a fibre with the organism that ferments it is the synbiotic pairing.
L. plantarum carries a wide set of carbohydrate active enzymes and uses the arabinose and galactose fragments released as the polysaccharide is degraded. That gives the delivered culture a substrate on arrival.
Butyrate is one of the short chain fatty acids the colonic community produces from fermentable fibre such as arabinogalactan. Supplying both gives the end product directly while keeping the endogenous route fed.
Inulin ferments fast and early in the colon while arabinogalactan ferments more slowly and further along. Blending them spreads short chain fatty acid production over a longer stretch.
Beta glucan is recognised directly by dectin-1 on innate immune cells, while arabinogalactan works mainly through the gut community and its metabolites. The routes are separate rather than duplicated.
Pectin contributes a gelling galacturonan fraction and a different set of fermentable side chains from those in arabinogalactan. Fibre blends combine them for that breadth of substrate.
Psyllium is viscous and largely unfermented while arabinogalactan is non viscous and highly fermented. Together they cover both the bulking and the fermentation side of fibre.
PHGG is another low viscosity soluble fibre with a slow, distal fermentation pattern, so blending it with arabinogalactan raises total fermentable load without raising thickness. Both are chosen for beverages for that reason.
Fermentation of soluble fibre lowers colonic pH and keeps divalent minerals soluble for longer, which supports uptake in the large bowel. The effect is most fully characterised for fructans and is inferred for other fermentable fibres.
Bifidobacteria carry beta-galactosidases and dedicated oligosaccharide transporters, which is why galactose-containing substrates are fermented readily. Arabinogalactan is a larger polymer than GOS and is degraded more slowly and further down the colon, so the two reach partly different sites. Combining chain lengths spreads fermentation rather than concentrating it.
Short fructans are consumed quickly by proximal colonic bacteria, while a branched arabinogalactan needs a wider set of glycoside hydrolases and persists further along. Pairing them distributes short-chain fatty acid production over more of the colon. Rapid fermenters also carry a higher chance of gas and bloating at higher doses, which the slower polymer does not offset.
Resistant starch fermentation is strongly butyrogenic through cross-feeding between primary degraders and butyrate producers, whereas arabinogalactan fermentation reported in vitro tends toward propionate alongside butyrate. Different substrates therefore shift the short-chain fatty acid mix, a measurable marker rather than a clinical endpoint. The pairing broadens which taxa have something to eat.
B. lactis carries the glycoside hydrolases needed for galactose-containing substrates, so co-dosing gives the introduced organism a carbon source in the same transit window. The mechanism is well established for prebiotic and probiotic pairing generally; strain-plus-arabinogalactan combination data specifically is thinner. Growth of a strain is a marker, not an outcome.
Lactobacilli ferment available carbohydrate to lactate, which is then cross-fed by butyrate-producing bacteria such as Eubacterium and Anaerostipes. Arabinogalactan supplies that upstream carbohydrate. The cross-feeding chain is well described; how much of it a given dose produces is not fixed.
S. boulardii does not depend on a prebiotic substrate the way a bacterium does, since it is transient and not a resident fermenter. Its pairing with arabinogalactan is a formulation convention rather than a substrate relationship. Naming that distinction is more accurate than calling it a synbiotic.
Inulin from chicory spans a range of chain lengths and is fermented largely in the proximal colon; arabinogalactan is branched and slower. Combining them is how formulators cover more of the colon with one blend. Higher combined doses raise fermentation gas, which is the practical limit on stacking fermentable fibres.
Oat beta-glucan raises the viscosity of gut contents, which is the physical property behind its effects on the rate of nutrient absorption. Arabinogalactan dissolves clear and thin and does not do that. Pairing them gives one viscous and one non-viscous fermentable fibre in a single product, two separate functions rather than a stronger version of one.
Guar galactomannan carries the same galactose-plus-mannose sugars bacterial enzymes handle well, so fermentation overlaps with a galactan. Its high native viscosity is the difference, and is why it is usually partially hydrolysed for beverage use. The two together contribute both a thickening and a non-thickening fermentable fraction.
Glucomannan takes up a large volume of water and is among the most viscous of the food polysaccharides, which is a physical effect on gastric emptying and satiety signalling. Arabinogalactan contributes fermentable substrate without that bulk. The two occupy different roles in a blend and should be dosed with the water intake glucomannan requires.
Short-chain fatty acids produced during fermentation acidify the colonic lumen, keeping calcium in solution and available for the paracellular absorption that continues past the small intestine. This is the accepted mechanism behind prebiotic effects on mineral absorption markers, demonstrated most often with inulin-type fructans. For arabinogalactan specifically the inference is from the shared pH mechanism, not from a dedicated trial.
Magnesium absorption continues in the distal gut through passive paracellular movement, which depends on the ion staying in solution. Fermentation acidity supports that. The pairing acts on an absorption marker rather than on a measured change in magnesium status.
Iron is absorbed mainly in the duodenum, upstream of where fibre is fermented, so the pH mechanism that favours calcium is less relevant to it. What a bulk polysaccharide can do is slow gastric emptying and dilute a mineral dose in the upper gut. The net direction for iron is uncertain, so this is flagged as a modulating pairing rather than an enhancement.
Several gut genera including Bacteroides produce long-chain menaquinones as part of their own respiratory metabolism. Supplying fermentable carbohydrate supports the populations that do so. Whether bacterially produced menaquinone in the colon contributes meaningfully to human vitamin K status is not settled, which keeps this at early confidence.
Lactoferrin sequesters free iron, which restricts iron-dependent organisms while bifidobacteria manage with little. Arabinogalactan works by feeding those same bifidobacteria a carbon source. Two different levers on the same population, with no combination trial to size the joint effect.
Nothing specific on file for Arabinogalactan. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Arabinogalactan actually does.
Arabinogalactans are branched sugar chains with a galactose backbone and arabinose side chains. Larch arabinogalactan is the heavily branched type II sort, built on a beta-1,3-galactan core with beta-1,6-linked side chains.
Your own digestive enzymes can't cut beta-1,3 and beta-1,6 galactosyl links, so essentially all of it reaches the colon intact. That's what makes it a dietary fibre by definition rather than a carbohydrate you digest.
Colon bacteria carrying arabinofuranosidases and beta-galactosidases break the polymer down to fermentable sugars and then to short-chain fatty acids, mainly acetate, propionate and butyrate, which the cells lining your colon burn for energy.
Making short-chain fatty acids lowers the pH inside the colon, and that shift changes how soluble the divalent minerals are and what growing conditions the pH-sensitive bacterial groups get.
Where Arabinogalactan comes from.
Most of it is pulled out of larch wood with hot water, filtered clean, tested, then dried into a powder that dissolves without going thick. The other version, gum arabic, is simply the hardened sap collected from acacia trees, cleaned and ground.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
The commodity source is milled heartwood of Larix occidentalis or Larix sibirica, usually a by-product stream of timber processing; the alternative route is hand-collected hardened gum from tapped Acacia trees.
Wood chips are counter-currently extracted with hot water, which dissolves the arabinogalactan while the lignin and cellulose stay in the solid residue.
The liquor is clarified, then ultrafiltered or treated with adsorbent to remove low molecular weight sugars, phenolics and colour from the polysaccharide fraction.
The concentrate is assayed for arabinogalactan or total dietary fibre by an enzymatic-gravimetric method and adjusted to a declared minimum, with residual sugar and ash specified.
The purified solution is spray dried to a free-flowing powder that dissolves in cold water without a gel stage.
Whether a product is larch derived or acacia derived changes the actual molecule, since acacia carries a protein component larch does not, and a label reading only 'arabinogalactan' does not tell you which.
Getting Arabinogalactan from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In a double-blind crossover trial, daily arabinogalactan shifted the make-up of the gut microbiome compared with placebo, changing the balance of fibre-fermenting bacterial groups.Randomised trial. Chen et al., 2021 (Nutrition). PMID 34004416 ↗
- Using 16S rRNA gene sequencing of human gut microbial communities, the authors report that arabinogalactan shifted the relative abundance of specific bacterial taxa consistent with prebiotic activity; taxa abundance is a marker, not a clinical outcome.In vitro study. Rasoulimehrabani H et al., 2025 (Microbiome Research Reports). PMID 41133092 ↗
- A carbohydrate-rich leaf extract, characterised in part by its arabinogalactan content, showed prebiotic-related activity in vitro and altered metabolic measures in animals; the material tested was a whole plant extract rather than isolated arabinogalactan.Animal study. de Bessa ME et al., 2026 (Plant Foods for Human Nutrition). PMID 41863557 ↗
- A characterised ginger polysaccharide altered energy-related measures in rodents on a high-fat diet; arabinogalactan-type structures appear in the compositional characterisation rather than as the tested substance.Animal study. Liang L et al., 2025 (Journal of Agricultural and Food Chemistry). PMID 40845327 ↗
- Polysaccharides from wheat cell culture, described compositionally as including arabinogalactan structures, showed immunoregulatory activity in laboratory assays.In vitro study. Murtazina A et al., 2026 (Molecules). PMID 42123902 ↗
- A review of gum acacia, an arabinogalactan-protein exudate, summarising reported effects on male reproductive measures across mostly preclinical reports.Narrative review. Firouzabadi AM et al., 2026 (American Journal of Men's Health). PMID 41677326 ↗
These are the studies our verdict leans on, chosen from the 1,239 we read for Arabinogalactan. The full linked list is below.
The studies, linked.
4 sources behind our Arabinogalactan verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialA Randomized, Double-blind, Placebo-controlled, Crossover Study to Investigate the Effect of an Arabinogalactan Product for 6 Weeks on the Gut Microbiome in AdultsClinicalTrials.gov ↗NA · 30 participants · Completed
- Clinical trialPilot Study on Safety and Performance of an Artificial Tear Containing Arabinogalactan, Trehalose and Hyaluronic Acid in the Treatment of Dry Eye in Subjects With Inflammation of the Ocular SurfaceClinicalTrials.gov ↗NA · 24 participants · Completed
- Clinical trialAn Acute, Randomized, Double-blind, Controlled, Crossover Study to Investigate the Effect of an Arabinogalactan Product on Glucose and Insulin Response in AdultsClinicalTrials.gov ↗NA · 20 participants · Completed
- Clinical trialResistant Starch and Non-starch Polysaccharide (Dietary Fibre) Intake in Relation to the Structure and Metabolic Activities of the Colonic Microbiome in Older PeopleClinicalTrials.gov ↗NA · Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 52 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Arabinogalactan is, not how risky it is. A report is not proof Arabinogalactan caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
